205 related articles for article (PubMed ID: 11895856)
1. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.
Shibata A; Parsonnet J; Longacre TA; Garcia MI; Puligandla B; Davis RE; Vogelman JH; Orentreich N; Habel LA
Carcinogenesis; 2002 Mar; 23(3):419-24. PubMed ID: 11895856
[TBL] [Abstract][Full Text] [Related]
2. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.
Magalhães PP; Queiroz DM; Camargo AA; Simpson AJ
Carcinogenesis; 2003 Jan; 24(1):145; author reply 147. PubMed ID: 12538360
[No Abstract] [Full Text] [Related]
3. Association between CagA+ Helicobacter pylori infection and p53, bax and transforming growth factor-beta-RII gene mutations in gastric cancer patients.
Deguchi R; Takagi A; Kawata H; Inoko H; Miwa T
Int J Cancer; 2001 Feb; 91(4):481-5. PubMed ID: 11251969
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of the intact cag pathogenicity island in clinical isolates of Helicobacter pylori in Karachi, Pakistan.
Yakoob J; Jafri W; Abbas Z; Abid S; Khan R; Jafri N; Ahmad Z
Br J Biomed Sci; 2009; 66(3):137-42. PubMed ID: 19839224
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
6. CagA tyrosine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma.
Lai YP; Yang JC; Lin TZ; Wang JT; Lin JT
Helicobacter; 2003 Jun; 8(3):235-43. PubMed ID: 12752736
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.
Peters TM; Owen RJ; Slater E; Varea R; Teare EL; Saverymuttu S
J Clin Pathol; 2001 Mar; 54(3):219-23. PubMed ID: 11253135
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: an association with histopathological parameters.
Lima VP; Silva-Fernandes IJ; Alves MK; Rabenhorst SH
Cancer Epidemiol; 2011 Oct; 35(5):e32-7. PubMed ID: 21470935
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
[TBL] [Abstract][Full Text] [Related]
10. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
[TBL] [Abstract][Full Text] [Related]
11. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications.
Graham DY; Yamaoka Y
Helicobacter; 1998 Sep; 3(3):145-51. PubMed ID: 9731983
[TBL] [Abstract][Full Text] [Related]
12. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION?
Oliveira AKS; Silva LLL; Miguel MP; Blanco AJV; Carneiro LC; Barbosa MS
Arq Gastroenterol; 2021; 58(4):468-475. PubMed ID: 34909852
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relationship between dietary factors, CagA-positive Helicobacter pylori infection, and RUNX3 promoter hypermethylation in gastric cancer tissue.
Zhang YW; Eom SY; Yim DH; Song YJ; Yun HY; Park JS; Youn SJ; Kim BS; Kim YD; Kim H
World J Gastroenterol; 2013 Mar; 19(11):1778-87. PubMed ID: 23555166
[TBL] [Abstract][Full Text] [Related]
14. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
16. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity.
Loh JT; Shaffer CL; Piazuelo MB; Bravo LE; McClain MS; Correa P; Cover TL
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2237-49. PubMed ID: 21859954
[TBL] [Abstract][Full Text] [Related]
18. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection.
Yea SS; Yang YI; Jang WH; Lee YJ; Bae HS; Paik KH
J Clin Pathol; 2001 Sep; 54(9):703-6. PubMed ID: 11533078
[TBL] [Abstract][Full Text] [Related]
19. Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression.
André AR; Ferreira MV; Mota RM; Ferrasi AC; Pardini MI; Rabenhorst SH
Cancer Epidemiol; 2010 Oct; 34(5):618-25. PubMed ID: 20541486
[TBL] [Abstract][Full Text] [Related]
20. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
